Eling Pharmaceutical (002603.SZ): Innovative traditional Chinese medicine “Qiqin Tongping Tablets” obtained a drug registration certificate

Zhitongcaijing · 3d ago

Zhitong Finance App News, Eling Pharmaceutical (002603.SZ) issued an announcement. Recently, Beijing Yiling Pharmaceutical Co., Ltd. (“Beijing Yiling” for short), a wholly-owned subsidiary of the company, received the “Drug Registration Certificate” approved and issued by the State Drug Administration. The application for marketing registration of the new drug “Qi Gui Luo Pill” (approval name: Qi Qintong Pill) submitted by Beijing Eling has been officially approved.

Qi Qintong Pill is a Class 1.1 innovative traditional Chinese medicine developed independently by the company to treat active rheumatoid arthritis rheumatoid arthritis, rheumatic fever, and paralysis. Its main functions are: to remove wind and humidity, relieve paralysis, relieve cold and pain. It is used in combination with methotrexate for joint pain, joint swelling, worsening when cold, and restricted joint activity due to rheumatoid arthritis during active rheumatoid arthritis. The company has independent and complete intellectual property rights for this drug.